Clascoterone Powder For Hair

Drug Name: Clascoterone
Indication: Androgenetic Alopecia (AGA), commonly known as male-pattern or female-pattern hair loss.

Overview

Clascoterone is a first-in-class, topically applied androgen receptor inhibitor. It is the first and currently only topical androgen receptor inhibitor approved by the U.S. FDA for the treatment of acne. Based on its mechanism of action, it is also extensively researched for the treatment of androgenetic alopecia and has shown significant potential.

packing &shipping:

Delivery Time:Around 3-5 workdays after your payment.

Package:1kg/aluminium foil bag;25Kgs in fiber-drums with two-plastic bags inside

Net Weight:25kgs/Drum/GrossWeight:28kgs/Drum

Drum Size & Volume:I.D.42cm × H52cm,0.08 m³/Drum

In the hair care and anti-hair loss category, our main products include: RU58841, Minoxidil, and Clascoterone. We offer direct factory supply at competitive prices. Inquiries are welcome.

Clascoterone is primarily an androgen receptor inhibitor, approved for treating acne. For hair care, its potential lies in addressing androgenetic alopecia (pattern hair loss). It works topically on the scalp to block DHT (the hormone that shrinks follicles) at the receptor level, potentially slowing hair loss and promoting regrowth.

While not yet FDA-approved for hair loss, it has gained significant popularity in the Mexican market​ as an off-label treatment. This trend is driven by:

High Demand:​ Strong cultural emphasis on hair and aesthetics fuels demand for innovative treatments.

Accessibility:​ Medical regulations sometimes allow earlier off-label use, and clinics often promote it as a novel, topical alternative with potentially fewer systemic side effects than oral medications.

Marketing:​ It is frequently presented in private dermatology and hair restoration clinics as a "next-generation" topical solution.

Important Note:​ Although popular, its use for hair loss in Mexico is still largely off-label and investigational. Robust, long-term clinical data for this specific application is still pending. Consumers should seek professional medical advice to understand the evidence, potential risks, and appropriate use.